Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Bausch Health Companies Inc. (BHC)

26.37   -0.04 (-0.15%) 01-17 17:19
Open: 26.18 Pre. Close: 26.41
High: 26.75 Low: 25.65
Volume: 4,522,065 Market Cap: 9,423M
Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 26.781 - 26.922 26.922 - 27.042
Low: 25.322 - 25.479 25.479 - 25.612
Close: 26.107 - 26.379 26.379 - 26.61

Technical analysis

as of: 2021-01-15 4:38:07 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 31.24     One year: 36.49
Support: Support1: 22.28    Support2: 19.52
Resistance: Resistance1: 26.75    Resistance2: 31.24
Pivot: 22.52
Moving Average: MA(5): 25.11     MA(20): 22.03
MA(100): 18.52     MA(250): 19.05
MACD: MACD(12,26): 1.52     Signal(9): 1.01
Stochastic oscillator: %K(14,3): 96.46     %D(3): 95.24
RSI: RSI(14): 85.22
52-week: High: 30.15  Low: 11.15  Change(%): -11.3
Average Vol(K): 3-Month: 360822  10-Days: 477825

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
BHC has closed below upper band by 6.4%. Bollinger Bands are 198.4% wider than normal. The large width of the bands suggest high volatility as compared to BHC's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

Fri, 15 Jan 2021
Bausch Health Companies (NYSE:BHC) PT Raised to $33.00 at Jefferies Financial Group - MarketBeat

Wed, 13 Jan 2021
Why Bausch Health Stock Jumped 10% Today - Motley Fool

Wed, 13 Jan 2021
Should You Buy Bausch Health Companies Inc (BHC) Stock Wednesday? - InvestorsObserver

Wed, 13 Jan 2021
The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations - Benzinga

Tue, 12 Jan 2021
Bausch Health Co. Inc. (BHC) Guides Q4 Revenue Ahead of Consensus -

Wed, 06 Jan 2021
Bausch Health To Participate At The 39th Annual J.P. Morgan Healthcare Conference - Yahoo Finance

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Outperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 355
Shares Float (M) 309
% Held by Insiders 0.56
% Held by Institutions 66.75
Shares Short (K) 13,970
Shares Short P. Month (K) 15,980

Stock Financials

EPS -5.440
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 1.650
Profit Margin -23.92
Operating Margin 15.30
Return on Assets (ttm) 2.4
Return on Equity (ttm) -119.7
Qtrly Rev. Growth -3.2
Gross Profit (p.s.) 17.606
Sales Per Share 22.649
EBITDA (p.s.) 8.789
Qtrly Earnings Growth
Operating Cash Flow (M) 951
Levered Free Cash Flow (M) 1,480

Stock Valuations

PE Ratio -4.85
PEG Ratio
Price to Book value 15.98
Price to Sales 1.16
Price to Cash Flow 9.84

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date 2010-11-09
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.